YGR066C Antibody

Shipped with Ice Packs
In Stock

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
YGR066C antibody; Uncharacterized protein YGR066C antibody
Target Names
YGR066C
Uniprot No.

Q&A

What is YGR066C and why are antibodies against it important for research?

YGR066C is a systematic name for a gene in Saccharomyces cerevisiae (baker's yeast). Antibodies against the protein encoded by this gene serve as critical tools for investigating its expression, localization, and function in cellular processes. These antibodies enable techniques such as Western blotting, immunoprecipitation, immunofluorescence microscopy, and chromatin immunoprecipitation, providing researchers with methods to study the protein's role in yeast biology.

What are the recommended validation methods for YGR066C antibodies?

Proper validation of YGR066C antibodies should include multiple complementary approaches:

  • Western blot analysis comparing wild-type yeast with YGR066C knockout strains

  • Immunoprecipitation followed by mass spectrometry to confirm specific protein capture

  • Immunofluorescence with appropriate controls including peptide competition assays

  • Testing across multiple experimental conditions to ensure consistent performance

  • Validation across different batches to ensure reproducibility

These validation methods help ensure experimental results are based on specific antibody-target interactions rather than cross-reactivity or non-specific binding.

How should researchers compare polyclonal versus monoclonal antibodies for YGR066C research?

The choice between polyclonal and monoclonal antibodies for YGR066C research depends on experimental requirements:

Antibody TypeAdvantagesDisadvantagesBest Applications
Polyclonal- Recognizes multiple epitopes
- Higher sensitivity
- More robust to protein denaturation
- Batch-to-batch variation
- Higher background potential
- Limited supply
- Western blotting
- Immunohistochemistry
- Initial protein characterization
Monoclonal- Consistent specificity
- Renewable source
- Lower background
- May be sensitive to epitope changes
- Potentially lower avidity
- More affected by protein modifications
- Flow cytometry
- Protein purification
- Therapeutic applications

For novel YGR066C research, both antibody types might be employed sequentially: polyclonal antibodies for initial detection and characterization, followed by monoclonal antibodies for more specific applications requiring consistency across experiments.

How can antibody-cell conjugation (ACC) techniques be applied to YGR066C research?

Antibody-cell conjugation techniques represent an advanced approach for YGR066C research, particularly in studying protein-protein interactions or developing targeted cellular systems:

For YGR066C studies, researchers could apply ACC using several methods described in recent literature:

  • Metabolic sugar engineering to introduce azide moieties onto cell surfaces, followed by antibody conjugation via bioorthogonal reactions

  • Chemoenzymatic methods utilizing enzymes like α-1,3-fucosyltransferase to transfer antibodies conjugated to GDP-fucose onto cell surface glycocalyxes

  • Direct modification of cell surfaces using NHS-DNA couplings that allow sequence-dependent capture of cells

These ACC techniques could be particularly valuable for creating yeast cells with targeted YGR066C antibodies to study protein interactions in complex cellular environments or to develop biosensor systems based on YGR066C function.

What role can cryoEM play in characterizing antibodies against YGR066C?

CryoEM has emerged as a powerful tool for characterizing antibody-antigen interactions with high resolution and can be applied to YGR066C research:

  • Epitope Mapping: CryoEM can provide detailed structural information about where YGR066C antibodies bind to their target protein, revealing key interaction sites with 3.3-3.7Å resolution

  • Polyclonal Antibody Analysis: The cryoEMPEM (cryoEM polyclonal epitope mapping) approach can be used to identify families of antibodies that recognize different epitopes on the YGR066C protein, providing insights into the immune response against this target

  • Structure-Based Sequence Inference: By combining cryoEM with next-generation sequencing data, researchers can identify the variable regions and CDRs of antibodies that bind to YGR066C, enabling rapid development of monoclonal antibodies without traditional screening methods

This approach is particularly valuable for understanding complex antibody responses and can accelerate the development of highly specific monoclonal antibodies against YGR066C.

How can researchers design bispecific antibodies targeting YGR066C and related proteins?

Bispecific antibodies that recognize both YGR066C and other proteins of interest represent an advanced research tool with several applications:

  • Anchoring Strategy: Following the model demonstrated in SARS-CoV-2 research, researchers can develop a dual-antibody approach where one antibody targets a conserved region of YGR066C (serving as an anchor), while a second antibody targets a functional domain

  • Design Methodology:

    • Identify conserved regions in YGR066C that show minimal variation across conditions

    • Engineer antibody pairs where one targets this conserved region

    • Design the second antibody to recognize functional domains or interaction sites

    • Test combinations for synergistic effects through binding assays

  • Applications:

    • Studying protein-protein interactions involving YGR066C

    • Investigating conformational changes in the protein

    • Developing detection systems with enhanced specificity

    • Creating targeted research tools for complex cellular studies

This approach can be particularly valuable when studying proteins that undergo conformational changes or have multiple interaction partners.

What are the optimal methods for coupling YGR066C antibodies to cells for targeted studies?

Based on recent advances in antibody-cell conjugation, researchers working with YGR066C have several methodological options:

  • Metabolic Glycoengineering Approach:

    • Introduce azide moieties onto cell surfaces using 9-azido N-acetylneuraminic acid methyl ester

    • Modify YGR066C antibodies with DBCO-PEG4-NHS ester

    • Couple via bioorthogonal azide-alkyne click chemistry reaction

    • This approach is minimally disruptive to cellular function while providing stable conjugation

  • Fucosyltransferase-Mediated Coupling:

    • Utilize H. pylori 26695 α-1,3-FucT enzyme's substrate tolerance

    • Couple YGR066C antibodies to GDP-fucose

    • Transfer to cell surface glycocalyxes in a single-step operation

    • Optional pre-desialylation step to increase coupling density

    • This method offers rapid coupling (minutes) without genetic modification

  • DNA-Mediated Assembly:

    • Attach single-stranded DNA to YGR066C antibodies

    • Couple complementary DNA strands to cell surface proteins

    • Hybridize complementary strands to attach antibodies to cells

    • This approach allows for controlled, reversible attachment and multi-component assembly

Each method has specific advantages depending on research goals, with selection based on factors including required stability, coupling density, and compatibility with downstream applications.

How can researchers troubleshoot selectivity and specificity issues with YGR066C antibodies?

Selectivity and specificity challenges represent significant hurdles in YGR066C antibody research. Methodological approaches to address these include:

  • Epitope Analysis and Engineering:

    • Conduct comprehensive epitope mapping using techniques like cryoEM

    • Identify unique regions of YGR066C protein for antibody targeting

    • Engineer antibodies targeting multiple epitopes for increased specificity

    • Validate specificity across related proteins to confirm selectivity

  • Validation Protocol Sequence:

    • Begin with knockout/knockdown controls to verify absence of signal

    • Perform peptide competition assays to confirm epitope specificity

    • Test across multiple experimental conditions to ensure consistent performance

    • Evaluate in different cellular contexts to identify potential cross-reactivity

  • Advanced Binding Assessment:

    • Employ biolayer interferometry (BLI) to measure binding kinetics

    • Use sandwich ELISA assays to confirm specificity

    • Determine EC50 values and dissociation constants (Kd) for quantitative comparison

    • Test binding in complex biological matrices to assess real-world performance

Systematic application of these troubleshooting approaches can significantly improve antibody performance in challenging experimental contexts.

What techniques are recommended for identifying polyclonal antibody families against YGR066C?

Identifying polyclonal antibody families in YGR066C research can be accomplished through several complementary approaches:

  • CryoEM Polyclonal Epitope Mapping (cryoEMPEM):

    • Form complexes between YGR066C protein and polyclonal antibodies

    • Obtain high-resolution (3.3-3.7Å) cryoEM maps of these complexes

    • Analyze the structural characteristics of bound antibodies

    • Use focused classification approaches to reduce heterogeneity and improve map quality

  • Integration with Next-Generation Sequencing:

    • Isolate YGR066C-specific B cells from immunized animals or patients

    • Perform NGS on the B cell receptor repertoire

    • Develop hierarchical assignment systems for structure-based sequence inference

    • Apply scoring metrics for alignment of predicted and actual sequences

  • Validation of Identified Sequences:

    • Synthesize antibodies based on predicted sequences

    • Test binding using biolayer interferometry and ELISA assays

    • Verify structural agreement through cryoEM analysis of purified antibodies

    • Compare binding profiles with the original polyclonal mixture

This integrated approach offers significant advantages over traditional methods by starting with epitope information and working backward to identify antibody families, circumventing lengthy screening processes.

How can YGR066C antibodies be used to track protein dynamics in live yeast cells?

Tracking YGR066C protein dynamics in live cells requires specialized approaches that maintain cell viability while providing specific detection:

  • Minimally Disruptive Labeling Strategies:

    • Utilize chemoenzymatic methods that avoid genetic modification

    • Apply H. pylori-derived α-1,3-fucosyltransferase (α-1,3-FucT) for rapid coupling

    • Select smaller antibody fragments (Fabs, nanobodies) to minimize interference

    • Validate that labeling doesn't alter protein function or localization

  • Live Imaging Protocol Development:

    • Optimize signal-to-noise ratio for detecting YGR066C-antibody complexes

    • Establish imaging frequency that balances temporal resolution with photobleaching

    • Incorporate reference markers to compensate for cell movement

    • Implement computational tracking algorithms specific to yeast cell morphology

  • Data Analysis Framework:

    • Apply trajectory analysis to quantify protein movement parameters

    • Implement clustering algorithms to identify distinct dynamic populations

    • Correlate movement patterns with cell cycle phases or stress responses

    • Develop statistical methods to distinguish random from directed movement

These approaches enable researchers to gather quantitative data on YGR066C behavior under various physiological conditions or genetic backgrounds.

What are the best practices for analyzing potential cross-reactivity of YGR066C antibodies with other yeast proteins?

Cross-reactivity analysis for YGR066C antibodies requires systematic evaluation:

  • Comprehensive Control Testing:

    • Test antibodies against YGR066C knockout strains as negative controls

    • Examine reactivity in related yeast species with varying YGR066C homology

    • Perform Western blots with whole-cell lysates to identify all reactive bands

    • Conduct immunoprecipitation followed by mass spectrometry to identify all captured proteins

  • Epitope-Based Cross-Reactivity Prediction:

    • Use structural information from cryoEM studies to identify the specific epitope

    • Perform in silico analysis to identify proteins with similar epitope structures

    • Test predicted cross-reactive proteins individually

    • Map the specific amino acid residues involved in binding

  • Quantitative Assessment Methods:

    • Determine binding kinetics for both target and potential cross-reactive proteins

    • Establish threshold values for acceptable cross-reactivity

    • Calculate specificity indices comparing on-target vs. off-target binding

    • Document all cross-reactivity findings for comprehensive reporting

These practices ensure that experimental results can be correctly interpreted and that potential artifacts from cross-reactivity are properly accounted for.

How can researchers integrate structural and functional data when using YGR066C antibodies?

Integrating structural and functional data provides comprehensive insights into YGR066C biology:

  • Structure-Function Correlation Approach:

    • Use cryoEM to map antibody binding sites on YGR066C at high resolution

    • Correlate binding locations with known functional domains

    • Design antibody panels targeting different structural regions

    • Assess functional impact of antibody binding to specific domains

  • Integrated Data Analysis Framework:

    • Combine structural binding data with functional assay results

    • Develop computational models predicting functional effects based on epitope location

    • Use machine learning approaches to identify patterns across multiple datasets

    • Create visualization tools that overlay structural and functional information

  • Validation Through Mutagenesis:

    • Design targeted mutations in antibody-binding regions

    • Assess both structural binding changes and functional consequences

    • Create structure-function maps based on mutational analysis

    • Use antibodies as probes to detect conformational changes upon mutation

This integrated approach enables researchers to move beyond descriptive studies to mechanistic understanding of how YGR066C structure relates to its cellular functions.

What emerging technologies might enhance YGR066C antibody research in the next five years?

Several emerging technologies show promise for advancing YGR066C antibody research:

  • Enhanced CryoEM Applications:

    • Improved throughput and resolution in cryoEM will enable more detailed epitope mapping

    • Direct imaging of serum antibodies will provide better understanding of abundance, affinity, and clonality

    • Integration with computational methods will accelerate monoclonal antibody discovery

    • Development of in situ structural imaging could allow visualization of YGR066C-antibody interactions in native cellular environments

  • Advanced Antibody Engineering:

    • Development of bispecific antibodies targeting multiple YGR066C domains simultaneously

    • Creation of antibody pairs where one serves as an anchor to conserved regions while another targets functional domains

    • Engineering antibodies resistant to environmental variations to improve experimental consistency

    • Development of photoswitchable antibodies for controlled binding studies

  • Integrated Single-Cell Technologies:

    • Combining single-cell transcriptomics with antibody repertoire analysis

    • Development of spatial antibody profiling in tissues and cell populations

    • Creation of multimodal assays that simultaneously measure multiple parameters

    • Integration of antibody data with other -omics approaches for systems biology studies

These technologies will likely transform how researchers approach YGR066C studies, providing more comprehensive and mechanistic insights.

How might synthetic biology approaches incorporate YGR066C antibodies for new applications?

Synthetic biology offers innovative ways to utilize YGR066C antibodies:

  • Engineered Cellular Circuits:

    • Create synthetic signaling pathways triggered by YGR066C-antibody interactions

    • Develop cellular sensors that respond to YGR066C levels or modifications

    • Design genetic circuits that are regulated by antibody-based inputs

    • Build cellular networks that model complex YGR066C-related processes

  • Antibody-Cell Conjugation Applications:

    • Develop cell-based delivery systems using YGR066C antibodies for targeting

    • Create multicellular assemblies with defined spatial organization using antibody-DNA scaffolds

    • Engineer cells with multiple antibody types for complex interaction studies

    • Design reversible cellular assembly systems controlled by external stimuli

  • Programmable Biological Materials:

    • Develop self-assembling protein structures using YGR066C antibodies as building blocks

    • Create responsive biomaterials that change properties based on antibody interactions

    • Design modular experimental systems with interchangeable antibody components

    • Build hierarchical biosensors incorporating multiple recognition elements

These synthetic biology approaches extend YGR066C antibody applications beyond traditional research tools to create novel experimental systems and potentially useful biotechnologies.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.